ORIGINAL RESEARCH
Published on 29 Sep 2021
Pioneering BRCA1/2 Point-Of-Care Testing for Integration of Germline and Tumor Genetics in Breast Cancer Risk Management: A Vision for the Future of Translational Pharmacogenomics
doi 10.3389/fonc.2021.619817
- 3,212 views
- 10 citations